These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 15031599)

  • 1. Mechanisms of paclitaxel-induced apoptosis in an ovarian cancer cell line and its paclitaxel-resistant clone.
    Sugimura M; Sagae S; Ishioka S; Nishioka Y; Tsukada K; Kudo R
    Oncology; 2004; 66(1):53-61. PubMed ID: 15031599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of docetaxel in paclitaxel-resistant ovarian cancer cells.
    Sato S; Kigawa J; Kanamori Y; Itamochi H; Oishi T; Shimada M; Iba T; Naniwa J; Uegaki K; Terakawa N
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):247-52. PubMed ID: 14610615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
    Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
    Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway.
    Chang MC; Chen CA; Hsieh CY; Lee CN; Su YN; Hu YH; Cheng WF
    Biochem J; 2009 Dec; 424(3):449-58. PubMed ID: 19747165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low doses of paclitaxel potently induce apoptosis in human retinoblastoma Y79 cells by up-regulating E2F1.
    Drago-Ferrante R; Santulli A; Di Fiore R; Giuliano M; Calvaruso G; Tesoriere G; Vento R
    Int J Oncol; 2008 Oct; 33(4):677-87. PubMed ID: 18813780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential sensitivity to paclitaxel-induced apoptosis and growth suppression in paclitaxel-resistant cell lines established from HEC-1 human endometrial adenocarcinoma cells.
    Tanaka T; Toujima S; Tanaka J
    Int J Oncol; 2012 Nov; 41(5):1837-44. PubMed ID: 22923148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epothilone-paclitaxel resistant leukemic cells CEM/dEpoB300 are sensitive to albendazole: Involvement of apoptotic pathways.
    Khalilzadeh A; Wangoo KT; Morris DL; Pourgholami MH
    Biochem Pharmacol; 2007 Aug; 74(3):407-14. PubMed ID: 17560963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53.
    Jones NA; Turner J; McIlwrath AJ; Brown R; Dive C
    Mol Pharmacol; 1998 May; 53(5):819-26. PubMed ID: 9584207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
    Goldwasser F; Bae I; Fornace AJ; Pommier Y
    Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
    Giannakakou P; Robey R; Fojo T; Blagosklonny MV
    Oncogene; 2001 Jun; 20(29):3806-13. PubMed ID: 11439344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular efflux pump and interaction between cisplatin and paclitaxel in ovarian cancer cells.
    Kamazawa S; Kigawa J; Minagawa Y; Itamochi H; Shimada M; Takahashi M; Sato S; Akeshima R; Terakawa N
    Oncology; 2000 Nov; 59(4):329-35. PubMed ID: 11096346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel.
    Debernardis D; Siré EG; De Feudis P; Vikhanskaya F; Valenti M; Russo P; Parodi S; D'Incalci M; Broggini M
    Cancer Res; 1997 Mar; 57(5):870-4. PubMed ID: 9041188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered levels and regulation of stathmin in paclitaxel-resistant ovarian cancer cells.
    Balachandran R; Welsh MJ; Day BW
    Oncogene; 2003 Dec; 22(55):8924-30. PubMed ID: 14654788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer.
    Coukos G; Makrigiannakis A; Kang EH; Rubin SC; Albelda SM; Molnar-Kimber KL
    Clin Cancer Res; 2000 Aug; 6(8):3342-53. PubMed ID: 10955822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis.
    Vikhanskaya F; Vignati S; Beccaglia P; Ottoboni C; Russo P; D'Incalci M; Broggini M
    Exp Cell Res; 1998 May; 241(1):96-101. PubMed ID: 9633517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
    Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
    Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
    Wen SF; Xie L; McDonald M; DiGiacomo R; Chang A; Gurnani M; Shi B; Liu S; Indelicato SR; Hutchins B; Nielsen LL
    Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effects of green tea extract and paclitaxel in the induction of mitochondrial apoptosis in ovarian cancer cell lines.
    Panji M; Behmard V; Zare Z; Malekpour M; Nejadbiglari H; Yavari S; Nayerpour Dizaj T; Safaeian A; Bakhshi A; Abazari O; Abbasi M; Khanicheragh P; Shabanzadeh M
    Gene; 2021 Jun; 787():145638. PubMed ID: 33848578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.